Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

Por Ridolfi, Ruggero, Petrini, Massimiliano, Fiammenghi, Laura, Stefanelli, Monica, Ridolfi, Laura, Ballardini, Michela, Migliori, Giuseppe, Riccobon, Angela
Publicado em 2006

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic...

Por Ridolfi, Laura, de Rosa, Francesco, Ridolfi, Ruggero, Gentili, Giorgia, Valmorri, Linda, Scarpi, Emanuela, Parisi, Elisabetta, Romeo, Antonino, Guidoboni, Massimo
Publicado em 2014

Evaluation of in vivo labelled dendritic cell migration in cancer patients

Por Ridolfi, Ruggero, Riccobon, Angela, Galassi, Riccardo, Giorgetti, Gianluigi, Petrini, Massimiliano, Fiammenghi, Laura, Stefanelli, Monica, Ridolfi, Laura, Moretti, Andrea, Migliori, Giuseppe, Fiorentini, Giuseppe
Publicado em 2004

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

Por Guida, Michele, Ravaioli, Alessandra, Sileni, Vanna Chiarion, Romanini, Antonella, Labianca, Roberto, Freschi, Antonio, Brugnara, Salvatore, Casamassima, Addolorata, Lorusso, Vito, Nanni, Oriana, Ridolfi, Ruggero
Publicado em 2003

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy

Por Fiammenghi, Laura, Ancarani, Valentina, Rosales, Tilman, Knutson, Jay R, Petrini, Massimiliano, Granato, Anna Maria, Pancisi, Elena, Ridolfi, Laura, Ridolfi, Ruggero, Riccobon, Angela, Neyroz, Paolo
Publicado em 2010

The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward

Por Maio, Michele, Nicolay, Hugues JM, Ascierto, Paolo, Belardelli, Filippo, Camerini, Roberto, Colombo, Mario P, Queirolo, Paola, Ridolfi, Ruggero, Russo, Vincenzo, Anzalone, Lucia, Fonsatti, Ester, Parmiani, Giorgio
Publicado em 2008

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-g...

Por Chiarion-Sileni, Vanna, Del Bianco, Paola, Romanini, Antonella, Guida, Michele, Paccagnella, Adriano, Dalla Palma, Maurizio, Naglieri, Emanuele, Ridolfi, Ruggero, Silvestri, Barbara, Michiara, Maria, De Salvo, Gian Luca
Publicado em 2006

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

Por Ridolfi, Laura, Petrini, Massimiliano, Fiammenghi, Laura, Granato, Anna Maria, Ancarani, Valentina, Pancisi, Elena, Scarpi, Emanuela, Guidoboni, Massimo, Migliori, Giuseppe, Sanna, Stefano, Tauceri, Francesca, Verdecchia, Giorgio Maria, Riccobon, Angela, Ridolfi, Ruggero
Publicado em 2010

Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”

Por Ridolfi, Laura, Petrini, Massimiliano, Fiammenghi, Laura, Granato, Anna Maria, Ancarani, Valentina, Pancisi, Elena, Scarpi, Emanuela, Guidoboni, Massimo, Migliori, Giuseppe, Sanna, Stefano, Tauceri, Francesca, Verdecchia, Giorgio Maria, Riccobon, Angela, Valmorri, Linda, Ridolfi, Ruggero
Publicado em 2011

The cost of unresectable stage III or stage IV melanoma in Italy

Por Maio Michele, Ascierto Paolo, Testori Alessandro, Ridolfi Ruggero, Bajetta Emilio, Queirolo Paola, Guida Michele, Romanini Antonella, Chiarion-Sileni Vanna, Pigozzo Jacopo, Di Giacomo Anna Maria, Calandriello Mario, Didoni Guido, van Baardewijk Marck, Konto Cyril, Lucioni Carlo
Publicado em 2012-11-01

The cost of unresectable stage III or stage IV melanoma in Italy

Por Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
Publicado em 2012

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

Por Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
Publicado em 2013

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients...

Por de Rosa, Francesco, Ridolfi, Laura, Ridolfi, Ruggero, Gentili, Giorgia, Valmorri, Linda, Nanni, Oriana, Petrini, Massimiliano, Fiammenghi, Laura, Granato, Anna Maria, Ancarani, Valentina, Pancisi, Elena, Soldati, Valentina, Cassan, Serena, Riccobon, Angela, Parisi, Elisabetta, Romeo, Antonino, Turci, Livia, Guidoboni, Massimo
Publicado no J Transl Med (2014)

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients

Por Ridolfi, Laura, Petrini, Massimiliano, Granato, Anna Maria, Gentilcore, Giusy, Simeone, Ester, Ascierto, Paolo Antonio, Pancisi, Elena, Ancarani, Valentina, Fiammenghi, Laura, Guidoboni, Massimo, de Rosa, Francesco, Valmorri, Linda, Scarpi, Emanuela, Nicoletti, Stefania Vittoria Luisa, Baravelli, Stefano, Riccobon, Angela, Ridolfi, Ruggero
Publicado em 2013

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Por Ascierto, Paolo A, Simeone, Ester, Sileni, Vanna Chiarion, Pigozzo, Jacopo, Maio, Michele, Altomonte, Maresa, Del Vecchio, Michele, Di Guardo, Lorenza, Marchetti, Paolo, Ridolfi, Ruggero, Cognetti, Francesco, Testori, Alessandro, Bernengo, Maria Grazia, Guida, Michele, Marconcini, Riccardo, Mandalà, Mario, Cimminiello, Carolina, Rinaldi, Gaetana, Aglietta, Massimo, Queirolo, Paola
Publicado em 2014

Defining the critical hurdles in cancer immunotherapy

Por Fox, Bernard A, Schendel, Dolores J, Butterfield, Lisa H, Aamdal, Steinar, Allison, James P, Ascierto, Paolo Antonio, Atkins, Michael B, Bartunkova, Jirina, Bergmann, Lothar, Berinstein, Neil, Bonorino, Cristina C, Borden, Ernest, Bramson, Jonathan L, Britten, Cedrik M, Cao, Xuetao, Carson, William E, Chang, Alfred E, Characiejus, Dainius, Choudhury, A Raja, Coukos, George, de Gruijl, Tanja, Dillman, Robert O, Dolstra, Harry, Dranoff, Glenn, Durrant, Lindy G, Finke, James H, Galon, Jerome, Gollob, Jared A, Gouttefangeas, Cécile, Grizzi, Fabio, Guida, Michele, Håkansson, Leif, Hege, Kristen, Herberman, Ronald B, Hodi, F Stephen, Hoos, Axel, Huber, Christoph, Hwu, Patrick, Imai, Kohzoh, Jaffee, Elizabeth M, Janetzki, Sylvia, June, Carl H, Kalinski, Pawel, Kaufman, Howard L, Kawakami, Koji, Kawakami, Yutaka, Keilholtz, Ulrich, Khleif, Samir N, Kiessling, Rolf, Kotlan, Beatrix, Kroemer, Guido, Lapointe, Rejean, Levitsky, Hyam I, Lotze, Michael T, Maccalli, Cristina, Maio, Michele, Marschner, Jens-Peter, Mastrangelo, Michael J, Masucci, Giuseppe, Melero, Ignacio, Melief, Cornelius, Murphy, William J, Nelson, Brad, Nicolini, Andrea, Nishimura, Michael I, Odunsi, Kunle, Ohashi, Pamela S, O'Donnell-Tormey, Jill, Old, Lloyd J, Ottensmeier, Christian, Papamichail, Michael, Parmiani, Giorgio, Pawelec, Graham, Proietti, Enrico, Qin, Shukui, Rees, Robert, Ribas, Antoni, Ridolfi, Ruggero, Ritter, Gerd, Rivoltini, Licia, Romero, Pedro J, Salem, Mohamed L, Scheper, Rik J, Seliger, Barbara, Sharma, Padmanee, Shiku, Hiroshi, Singh-Jasuja, Harpreet, Song, Wenru, Straten, Per Thor, Tahara, Hideaki, Tian, Zhigang, van Der Burg, Sjoerd H, von Hoegen, Paul, Wang, Ena, Welters, Marij JP, Winter, Hauke, Withington, Tara, Wolchok, Jedd D, Xiao, Weihua, Zitvogel, Laurence, Zwierzina, Heinz, Marincola, Francesco M, Gajewski, Thomas F, Wigginton, Jon M, Disis, Mary L
Publicado em 2011